Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
BACKGROUND: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on the e...
Guardat en:
| Publicat a: | CMAJ |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Canadian Medical Association
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12975222/ |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|